Key facts
- BANK OF AMERICA CORP /DE/ filed SCHEDULE 13G for Mereo BioPharma Group plc Ordinary shares (MREO).
- Disclosed ownership: 5.1%.
- Date of event: 31 Mar 2026.
BANK OF AMERICA CORP /DE/ - 31 Mar 2026 SCHEDULE 13G Report for Mereo BioPharma Group plc Ordinary shares (MREO)
- Filing Manager
- BANK OF AMERICA CORP /DE/
- Reporting Manager
- BANK OF AMERICA CORP /DE/
- Symbol
- MREO
- Shares outstanding
- 803,460,000 shares
- Disclosed Ownership
- 40,976,460 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 14 May 2026, 15:07:29 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Key filing fact
BANK OF AMERICA CORP /DE/ disclosed 5.1% ownership in Mereo BioPharma Group plc Ordinary shares (MREO) on 31 Mar 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2026, 15:07.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 5.1% | 40,976,460 | 0 | 40,976,460 | /s/ Monica Yako | Authorized Signatory |
CIK / CUSIP context first